111, Inc. Sponsored ADR Class A (YI.US) Southern Operations Center Guangdong Yihao Pharmaceutical was selected as one of the "Top 100 Private Enterprises in Guangdong Province" list.

Recently, the Guangdong Provincial Federation of Industry and Commerce released the "2025 Top 100 Private Enterprises in Guangdong Province" series of rankings. Guangdong Yihao Pharmaceutical Co., Ltd. (hereinafter referred to as "Guangdong Yihao Pharmaceutical") has been selected for the third consecutive year as one of the "Top 100 Private Enterprises in Guangdong Province", and has also been selected for the third consecutive year as one of the "Top 50 Private Enterprises in Guangdong Province". Founded in Zengcheng District, Guangzhou, Guangdong province, Guangdong Yihao Pharmaceutical is located in the Zhonghang Logistics Park, with a warehouse area exceeding 26,000 square meters. Since its establishment, the company has achieved rapid growth, with a total revenue of 3.25 billion yuan in 2024. As the core operating unit in South China for 111, Inc. Sponsored ADR Class A Group, Hub Group, Inc. Class A undertakes the mission of scaling up the group's B2B pharmaceutical distribution sector. Located in Guangzhou, a core city in the Greater Bay Area of Guangdong, Hong Kong, and Macau, the company has established a highly efficient pharmaceutical supply chain service system that covers the entire country. The company's business scope includes over 200,000 types of products such as pharmaceuticals, medical devices, and health products. Leveraging modern warehousing infrastructure, the company has integrated 111, Inc. Sponsored ADR Class A's leading advantages in intelligent supply chain, digital marketing, and user management to build an integrated pharmaceutical service network and omni-channel digital marketing platform. In terms of operational efficiency, Guangdong Yihao Pharmaceutical has effectively leveraged the R&D strength and digital innovation capabilities of the 111, Inc. Sponsored ADR Class A Group to reduce costs in various processes such as information transmission, communication, collaboration, warehouse management, and logistics transportation. As the strategic operational hub of the 111, Inc. Sponsored ADR Class A Group in South China, Guangdong Yihao Pharmaceutical will continue to focus on digital technology innovation and customer experience optimization. By relying on digital technology and intelligent supply chain core capabilities, the company aims to empower partners throughout the medical industry, enhance overall efficiency, promote the digital transformation of the pharmaceutical and healthcare industry, and create more value for society and the public. 111, Inc. Sponsored ADR Class A (YI.US) was established in 2010 and has built an integrated pharmaceutical health ecosystem centered around online retail pharmacy, self-operated offline pharmacies, online doctor-patient management platform, digital pharmaceutical distribution services, and SaaS-based health services. Currently, 111, Inc. Sponsored ADR Class A has established direct procurement strategic partnerships with over 500 domestic and international pharmaceutical companies. Its B2B platform "1" serves over 500,000 individual and small to medium-sized chain pharmacies nationwide, accounting for approximately 90% of the total number of pharmacies in the country. On September 12, 2018, 111, Inc. Sponsored ADR Class A was successfully listed on the NASDAQ stock exchange in the United States (stock code: YI), becoming the first Chinese Internet medical health company to be listed in the US.